Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A human monoclonal antibody blocking SARS-CoV-2 infection
Chunyan Wang, Wentao Li, Dubravka Drabek, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 1124

Showing 1-25 of 1124 citing articles:

Characteristics of SARS-CoV-2 and COVID-19
Ben Hu, Hua Guo, Peng Zhou, et al.
Nature Reviews Microbiology (2020) Vol. 19, Iss. 3, pp. 141-154
Open Access | Times Cited: 4742
Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19)
W. Joost Wiersinga, Andrew Rhodes, Allen C. Cheng, et al.
JAMA (2020) Vol. 324, Iss. 8, pp. 782-782
Closed Access | Times Cited: 4342
The trinity of COVID-19: immunity, inflammation and intervention
Matthew Zirui Tay, Chek Meng Poh, Laurent Rénia, et al.
Nature reviews. Immunology (2020) Vol. 20, Iss. 6, pp. 363-374
Open Access | Times Cited: 4293
Coronavirus biology and replication: implications for SARS-CoV-2
Philip V’kovski, Annika Kratzel, Silvio Steiner, et al.
Nature Reviews Microbiology (2020) Vol. 19, Iss. 3, pp. 155-170
Open Access | Times Cited: 2794
Mechanisms of SARS-CoV-2 entry into cells
Cody B. Jackson, Michael Farzan, Bing Chen, et al.
Nature Reviews Molecular Cell Biology (2021) Vol. 23, Iss. 1, pp. 3-20
Open Access | Times Cited: 2410
Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19
Yuan Huang, Chan Yang, Xin-feng Xu, et al.
Acta Pharmacologica Sinica (2020) Vol. 41, Iss. 9, pp. 1141-1149
Open Access | Times Cited: 2136
Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody
Dora Pinto, Young‐Jun Park, Martina Beltramello, et al.
Nature (2020) Vol. 583, Iss. 7815, pp. 290-295
Open Access | Times Cited: 1954
Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19
Takuya Sekine, André Perez‐Potti, Olga Rivera‐Ballesteros, et al.
Cell (2020) Vol. 183, Iss. 1, pp. 158-168.e14
Open Access | Times Cited: 1836
Immunology of COVID-19: Current State of the Science
Nicolas Vabret, Graham J. Britton, Conor Gruber, et al.
Immunity (2020) Vol. 52, Iss. 6, pp. 910-941
Open Access | Times Cited: 1654
Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike
Lihong Liu, Pengfei Wang, Manoj S. Nair, et al.
Nature (2020) Vol. 584, Iss. 7821, pp. 450-456
Open Access | Times Cited: 1515
A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2
Xiangyang Chi, Renhong Yan, Jun Zhang, et al.
Science (2020) Vol. 369, Iss. 6504, pp. 650-655
Open Access | Times Cited: 1481
Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology
Luca Piccoli, Young‐Jun Park, M. Alejandra Tortorici, et al.
Cell (2020) Vol. 183, Iss. 4, pp. 1024-1042.e21
Open Access | Times Cited: 1432
Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity
Wilfredo F. García-Beltrán, Evan C. Lam, Kerri St. Denis, et al.
Cell (2021) Vol. 184, Iss. 9, pp. 2372-2383.e9
Open Access | Times Cited: 1425
COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives
Masataka Nishiga, Dao Wen Wang, Yaling Han, et al.
Nature Reviews Cardiology (2020) Vol. 17, Iss. 9, pp. 543-558
Open Access | Times Cited: 1301
Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients’ B Cells
Yunlong Cao, Bin Su, Xianghua Guo, et al.
Cell (2020) Vol. 182, Iss. 1, pp. 73-84.e16
Open Access | Times Cited: 1275
Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability
Philip J. M. Brouwer, Tom G. Caniels, Karlijn van der Straten, et al.
Science (2020) Vol. 369, Iss. 6504, pp. 643-650
Open Access | Times Cited: 1271
The COVID-19 pandemic
Marco Ciotti, Massimo Ciccozzi, Alessandro Terrinoni, et al.
Critical Reviews in Clinical Laboratory Sciences (2020) Vol. 57, Iss. 6, pp. 365-388
Closed Access | Times Cited: 1237
mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant
Wilfredo F. García-Beltrán, Kerri St. Denis, Angelique Hœlzemer, et al.
Cell (2022) Vol. 185, Iss. 3, pp. 457-466.e4
Open Access | Times Cited: 1020
COVID-19: Transmission, prevention, and potential therapeutic opportunities
Melika Lotfi, Michael R. Hamblin, Nima Rezaei
Clinica Chimica Acta (2020) Vol. 508, pp. 254-266
Open Access | Times Cited: 985
N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2
Matthew McCallum, Anna De Marco, Florian A. Lempp, et al.
Cell (2021) Vol. 184, Iss. 9, pp. 2332-2347.e16
Open Access | Times Cited: 934
Beyond Shielding: The Roles of Glycans in the SARS-CoV-2 Spike Protein
Lorenzo Casalino, Zied Gaieb, Jory A. Goldsmith, et al.
ACS Central Science (2020) Vol. 6, Iss. 10, pp. 1722-1734
Open Access | Times Cited: 929
SARS-CoV-2: Structure, Biology, and Structure-Based Therapeutics Development
Mei-Yue Wang, Rong Zhao, Lijuan Gao, et al.
Frontiers in Cellular and Infection Microbiology (2020) Vol. 10
Open Access | Times Cited: 825
Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of Antibodies
Christopher O. Barnes, Anthony P. West, Kathryn E. Huey‐Tubman, et al.
Cell (2020) Vol. 182, Iss. 4, pp. 828-842.e16
Open Access | Times Cited: 822
COVID-19-neutralizing antibodies predict disease severity and survival
Wilfredo F. García-Beltrán, Evan C. Lam, Michael G. Astudillo, et al.
Cell (2020) Vol. 184, Iss. 2, pp. 476-488.e11
Open Access | Times Cited: 711
COVID-19 diagnosis —A review of current methods
Meral Yüce, Elif Filiztekin, Korin Ozkaya
Biosensors and Bioelectronics (2020) Vol. 172, pp. 112752-112752
Open Access | Times Cited: 660
Page 1 - Next Page

Scroll to top